These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 25694509)

  • 21. Cardiac injury after percutaneous catheter ablation for atrial fibrillation.
    Haegeli LM; Kotschet E; Byrne J; Adam DC; Lockwood EE; Leather RA; Sterns LD; Novak PG
    Europace; 2008 Mar; 10(3):273-5. PubMed ID: 18174208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Troponin T measured with highly sensitive assay (hsTnT) on admission does not reflect infarct size in ST-elevation myocardial infarction patients receiving primary percutaneous coronary intervention.
    Ferraro S; Corona S; Lavarra F; Panteghini M
    Clin Chem Lab Med; 2015 Jul; 53(8):e173-4. PubMed ID: 25781698
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
    Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
    Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiopoietin-like 4 serum levels on admission for acute myocardial infarction are associated with no-reflow.
    Bouleti C; Mathivet T; Serfaty JM; Vignolles N; Berland E; Monnot C; Cluzel P; Steg PG; Montalescot G; Germain S
    Int J Cardiol; 2015; 187():511-6. PubMed ID: 25863293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temporal repolarization inhomogeneity and reperfusion arrhythmias in patients undergoing successful primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: impact of admission troponin T.
    Bonnemeier H; Wiegand UK; Giannitsis E; Schulenburg S; Hartmann F; Kurowski V; Bode F; Tölg R; Katus HA; Richardt G
    Am Heart J; 2003 Mar; 145(3):484-92. PubMed ID: 12660672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of admission serum laboratory parameters with new-onset atrial fibrillation after a primary percutaneous coronary intervention.
    Karataş MB; Çanga Y; İpek G; Özcan KS; Güngör B; Durmuş G; Onuk T; Öz A; Şimşek B; Bolca O
    Coron Artery Dis; 2016 Mar; 27(2):128-34. PubMed ID: 26693808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical factors associated with the development of atrial fibrillation in the year following STEMI treated by primary PCI.
    Rhyou HI; Park TH; Cho YR; Park K; Park JS; Kim MH; Kim YD
    J Cardiol; 2018 Feb; 71(2):125-128. PubMed ID: 28969967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-sensitivity troponin T for early rule-out of myocardial infarction in recent onset chest pain.
    Aldous S; Pemberton C; Richards AM; Troughton R; Than M
    Emerg Med J; 2012 Oct; 29(10):805-10. PubMed ID: 22109535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do baseline atrial electrocardiographic and infarction patterns predict new-onset atrial fibrillation after ST-elevation myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction Trial.
    van Diepen S; Siha H; Fu Y; Westerhout CM; Lopes RD; Granger CB; Armstrong PW;
    J Electrocardiol; 2010; 43(4):351-8. PubMed ID: 20444469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early rule-out of acute coronary syndrome using undetectable levels of high sensitivity troponin T.
    Thelin J; Melander O; Öhlin B
    Eur Heart J Acute Cardiovasc Care; 2015 Oct; 4(5):403-9. PubMed ID: 25281765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is atrial fibrillation a risk factor for contrast-induced nephropathy in patients with ST-elevation myocardial infarction?
    Ballı M; Taşolar H; Çetin M; Hatem E; Çağlıyan ÇE; Şeker T; Çaylı M
    J Cardiol; 2016 Apr; 67(4):327-30. PubMed ID: 26589269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early Versus Late New-Onset Atrial Fibrillation in Acute Myocardial Infarction: Differences in Clinical Characteristics and Predictors.
    Shiyovich A; Axelrod M; Gilutz H; Plakht Y
    Angiology; 2019 Nov; 70(10):921-928. PubMed ID: 31387358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of using primary percutaneous coronary interventions on the incidence of new-onset atrial fibrillation following an acute myocardial infarction.
    Pan LH; Yan BY; Zhu J; Lu Q; Hui J
    Clin Cardiol; 2024 Jan; 47(1):e24167. PubMed ID: 37877780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of lymphocyte-to-monocyte ratio with the no-reflow phenomenon in patients who underwent a primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Kurtul A; Yarlioglues M; Celik IE; Duran M; Elcik D; Kilic A; Oksuz F; Murat SN
    Coron Artery Dis; 2015 Dec; 26(8):706-12. PubMed ID: 26340546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating cardiovascular biomarkers in recurrent atrial fibrillation: data from the GISSI-atrial fibrillation trial.
    Latini R; Masson S; Pirelli S; Barlera S; Pulitano G; Carbonieri E; Gulizia M; Vago T; Favero C; Zdunek D; Struck J; Staszewsky L; Maggioni AP; Franzosi MG; Disertori M;
    J Intern Med; 2011 Feb; 269(2):160-71. PubMed ID: 20964739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic impact of types of atrial fibrillation in acute coronary syndromes.
    Lau DH; Huynh LT; Chew DP; Astley CM; Soman A; Sanders P
    Am J Cardiol; 2009 Nov; 104(10):1317-23. PubMed ID: 19892044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated high-sensitive troponin T on admission is an indicator of poor long-term outcome in patients with subarachnoid haemorrhage: a prospective observational study.
    Oras J; Grivans C; Bartley A; Rydenhag B; Ricksten SE; Seeman-Lodding H
    Crit Care; 2016 Jan; 20():11. PubMed ID: 26781032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using high-sensitivity troponin T: the importance of the proper gold standard.
    Santaló M; Martin A; Velilla J; Povar J; Temboury F; Balaguer J; Muñoz M; Calmarza P; Ortiz C; Carratalá A; Gich I; Mercé J; Jaffe AS; Ordoñez-Llanos J
    Am J Med; 2013 Aug; 126(8):709-17. PubMed ID: 23764266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac magnetic resonance imaging study for quantification of infarct size comparing directly serial versus single time-point measurements of cardiac troponin T.
    Giannitsis E; Steen H; Kurz K; Ivandic B; Simon AC; Futterer S; Schild C; Isfort P; Jaffe AS; Katus HA
    J Am Coll Cardiol; 2008 Jan; 51(3):307-14. PubMed ID: 18206741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-sensitivity troponin T as a diagnostic tool for acute coronary syndrome in the real world: an observational study.
    Borna C; Thelin J; Ohlin B; Erlinge D; Ekelund U
    Eur J Emerg Med; 2014 Jun; 21(3):181-8. PubMed ID: 23751287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.